{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T10:01:21Z","timestamp":1787738481870,"version":"build-2784847793"},"reference-count":57,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ejso.2025.109731","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T19:11:34Z","timestamp":1740597094000},"page":"109731","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Management of peritoneal gastric metastasis: An update"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9626-0004","authenticated-orcid":false,"given":"Antoine","family":"Mariani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9801-8951","authenticated-orcid":false,"given":"Evangelia","family":"Triantafyllou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahan","family":"Kepenekian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aziz","family":"Zaanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Glehen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Karoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejso.2025.109731_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.ejso.2025.109731_bib2","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/ijc.28373","article-title":"Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors","volume":"134","author":"Thomassen","year":"2014","journal-title":"Int J Cancer"},{"issue":"10","key":"10.1016\/j.ejso.2025.109731_bib3","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1002\/bjs.1800821034","article-title":"Prospective study of prognostic factors in patients with unresected hepatic metastases from colorectal cancer. Fondation Fran\u00e7aise de Canc\u00e9rologie Digestive","volume":"82","author":"Rougier","year":"1995","journal-title":"Br J Surg"},{"issue":"32","key":"10.1016\/j.ejso.2025.109731_bib4","doi-asserted-by":"crossref","first-page":"52307","DOI":"10.18632\/oncotarget.10740","article-title":"Metastatic spread in patients with gastric cancer","volume":"7","author":"Riihim\u00e4ki","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejso.2025.109731_bib5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.21037\/dmr-21-94","article-title":"Gastric adenocarcinoma peritoneal carcinomatosis: a narrative review","volume":"5","author":"Green","year":"2022","journal-title":"Dig Med Res"},{"issue":"2","key":"10.1016\/j.ejso.2025.109731_bib6","doi-asserted-by":"crossref","first-page":"167","DOI":"10.6004\/jnccn.2022.0008","article-title":"Gastric cancer, version 2.2022, NCCN clinical practice guidelines in Oncology","volume":"20","author":"Ajani","year":"2022","journal-title":"J Natl Compr Cancer Netw JNCCN"},{"issue":"11","key":"10.1016\/j.ejso.2025.109731_bib7","doi-asserted-by":"crossref","first-page":"5656","DOI":"10.3390\/ijerph18115656","article-title":"Study protocol: phase I dose escalation study of oxaliplatin, cisplatin and doxorubicin applied as PIPAC in patients with peritoneal metastases","volume":"18","author":"Robella","year":"2021","journal-title":"Int J Environ Res Publ Health"},{"issue":"2","key":"10.1016\/j.ejso.2025.109731_bib8","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrclinonc.2009.217","article-title":"Intraperitoneal therapy for peritoneal tumors: biophysics and clinical evidence","volume":"7","author":"Ceelen","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2025.109731_bib9","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1001\/jamaoncol.2017.0515","article-title":"Effect of neoadjuvant chemotherapy followed by surgical resection on survival in patients with limited metastatic gastric or gastroesophageal junction cancer: the AIO-FLOT3 trial","volume":"3","author":"Al-Batran","year":"2017","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2025.109731_bib10","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1186\/s12885-017-3918-9","volume":"17","author":"Al-Batran","year":"2017","journal-title":"BMC Cancer"},{"issue":"21","key":"10.1016\/j.ejso.2025.109731_bib11","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.3390\/jcm10214882","article-title":"The burden of peritoneal metastases from gastric cancer: a systematic review on the incidence, risk factors and survival","volume":"10","author":"Rijken","year":"2021","journal-title":"J Clin Med"},{"issue":"10","key":"10.1016\/j.ejso.2025.109731_bib12","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.4240\/wjgs.v15.i10.2280","article-title":"Systematic review of diagnostic tools for peritoneal metastasis in gastric cancer-staging laparoscopy and its alternatives","volume":"15","author":"Ho","year":"2023","journal-title":"World J Gastrointest Surg"},{"issue":"6","key":"10.1016\/j.ejso.2025.109731_bib13","first-page":"732","article-title":"Gastric cancer: development and validation of a CT-based model to predict peritoneal metastasis","volume":"61","author":"Kim","year":"1987","journal-title":"Acta Radiol Stockh Swed"},{"issue":"12","key":"10.1016\/j.ejso.2025.109731_bib14","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2021.5340","article-title":"18F-Fludeoxyglucose-Positron emission tomography\/computed tomography and laparoscopy for staging of locally advanced gastric cancer: a multicenter prospective Dutch cohort study (PLASTIC)","volume":"156","author":"Gertsen","year":"2021","journal-title":"JAMA Surg"},{"key":"10.1016\/j.ejso.2025.109731_bib15","unstructured":"References with permission from the NCCN clinical practice guidelines in Oncology (NCCN Guidelines\u00ae) for guideline name Gastric Cancer, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. \u00a9 National Comprehensive Cancer Network, inc. 2024. All rights reserved. Accessed [01.20.2025]. To view the most recent and complete version of the guideline, go online NCCN.org."},{"key":"10.1016\/j.ejso.2025.109731_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1477-7800-2-3","article-title":"Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer","volume":"2","author":"Harmon","year":"2005","journal-title":"Int Semin Surg Oncol ISSO"},{"issue":"1","key":"10.1016\/j.ejso.2025.109731_bib17","first-page":"11","article-title":"Peritoneal metastasis in gastric cancer: results from the German database","volume":"23","author":"Rau","year":"2020","journal-title":"Gastric Cancer Off J Int Gastric Cancer Assoc Jpn Gastric Cancer Assoc."},{"issue":"3","key":"10.1016\/j.ejso.2025.109731_bib18","first-page":"146","article-title":"A new scoring system for peritoneal metastasis in gastric cancer","volume":"6","author":"Fujimura","year":"2003","journal-title":"Gastric Cancer Off J Int Gastric Cancer Assoc Jpn Gastric Cancer Assoc."},{"issue":"4","key":"10.1016\/j.ejso.2025.109731_bib19","doi-asserted-by":"crossref","first-page":"157","DOI":"10.23922\/jarc.2020-033","article-title":"Investigation of the Japanese classification of peritoneal metastasis from colorectal cancer referring to the correlation with PCI","volume":"4","author":"Kawasaki","year":"2020","journal-title":"J Anus Rectum Colon"},{"issue":"1","key":"10.1016\/j.ejso.2025.109731_bib20","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa073149","article-title":"Capecitabine and oxaliplatin for advanced esophagogastric cancer","volume":"358","author":"Cunningham","year":"2008","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.ejso.2025.109731_bib21","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1200\/JCO.2007.13.9378","article-title":"Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie","volume":"26","author":"Al-Batran","year":"2008","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"10294","key":"10.1016\/j.ejso.2025.109731_bib22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(21)00797-2","article-title":"First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial","volume":"398","author":"Janjigian","year":"2021","journal-title":"Lancet Lond Engl"},{"issue":"1","key":"10.1016\/j.ejso.2025.109731_bib23","doi-asserted-by":"crossref","first-page":"20","DOI":"10.7150\/jca.28204","article-title":"Pathological and prognostic impacts of FGFR2 overexpression in gastric cancer: a meta-analysis","volume":"10","author":"Kim","year":"2019","journal-title":"J Cancer"},{"key":"10.1016\/j.ejso.2025.109731_bib24","article-title":"Targeting CLDN18.2 in cancers of the gastrointestinal tract: new drugs and new indications","volume":"13","author":"Chen","year":"2023","journal-title":"Front Oncol"},{"issue":"9742","key":"10.1016\/j.ejso.2025.109731_bib25","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","article-title":"Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial","volume":"376","author":"Bang","year":"2010","journal-title":"Lancet Lond Engl"},{"issue":"10418","key":"10.1016\/j.ejso.2025.109731_bib26","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0140-6736(23)02033-0","article-title":"Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial","volume":"402","author":"Janjigian","year":"2023","journal-title":"Lancet Lond Engl"},{"issue":"4","key":"10.1016\/j.ejso.2025.109731_bib27","first-page":"408","article-title":"Phase III randomized trial comparing 5-fluorouracil and oxaliplatin with or without docetaxel in first-line advanced gastric cancer chemotherapy (GASTFOX study)","volume":"50","author":"Zaanan","year":"2018","journal-title":"Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver"},{"issue":"2","key":"10.1016\/j.ejso.2025.109731_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2023.102226","article-title":"Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with gastric cancer","volume":"9","author":"Shitara","year":"2024","journal-title":"ESMO Open"},{"issue":"19","key":"10.1016\/j.ejso.2025.109731_bib29","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1200\/JCO.2018.77.8613","article-title":"Phase III trial comparing intraperitoneal and intravenous paclitaxel plus S-1 versus cisplatin plus S-1 in patients with gastric cancer with peritoneal metastasis: PHOENIX-GC trial","volume":"36","author":"Ishigami","year":"2018","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2025.109731_bib30","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/jso.22057","article-title":"Intraperitoneal docetaxel combined with S-1 for advanced gastric cancer with peritoneal dissemination","volume":"105","author":"Fujiwara","year":"2012","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ejso.2025.109731_bib31","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2016.34.15_suppl.4040","article-title":"Phase II study of intraperitoneal paclitaxel plus S-1\/oxaliplatin for gastric cancer with peritoneal metastasis: SOX+IP PTX trial","volume":"34","author":"Fujiwara","year":"2016","journal-title":"JCO"},{"issue":"5","key":"10.1016\/j.ejso.2025.109731_bib32","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s00280-013-2122-0","article-title":"Phase I\/II study of intraperitoneal docetaxel plus S-1 for the gastric cancer patients with peritoneal carcinomatosis","volume":"71","author":"Fushida","year":"2013","journal-title":"Cancer Chemother Pharmacol"},{"issue":"2","key":"10.1016\/j.ejso.2025.109731_bib33","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1245\/s10434-023-14240-6","article-title":"Phase II study of intraperitoneal administration of paclitaxel combined with S-1 and cisplatin for gastric cancer with peritoneal metastasis","volume":"31","author":"Kobayashi","year":"2024","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2025.109731_bib34","first-page":"661","article-title":"Neoadjuvant treatment of gastric cancer with peritoneal dissemination","volume":"32","author":"Yonemura","year":"2006","journal-title":"Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"key":"10.1016\/j.ejso.2025.109731_bib35","series-title":"Comparing the efficacy and safety of intra-peritoneal infusion of catumaxomab and treatment of investigator choice in patients with advanced gastric carcinoma with peritoneal metastasis [internet]","year":"2023"},{"issue":"11","key":"10.1016\/j.ejso.2025.109731_bib36","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1245\/s10434-017-6047-4","article-title":"Phase II trial of laparoscopic hyperthermic intraperitoneal chemoperfusion for peritoneal carcinomatosis or positive peritoneal cytology in patients with gastric adenocarcinoma","volume":"24","author":"Badgwell","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2025.109731_bib37","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1245\/s10434-018-07140-7","article-title":"Laparoscopic hyperthermic intraperitoneal chemotherapy is safe for patients with peritoneal metastases from gastric cancer and may lead to gastrectomy","volume":"26","author":"Newhook","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"20","key":"10.1016\/j.ejso.2025.109731_bib38","doi-asserted-by":"crossref","first-page":"6527","DOI":"10.3390\/jcm12206527","article-title":"Current evidence for the use of HIPEC and cytoreductive surgery in gastric cancer metastatic to the peritoneum","volume":"12","author":"Jain","year":"2023","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.ejso.2025.109731_bib39","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s00464-017-5668-9","article-title":"Lessons learned from a phase II clinical trial of laparoscopic HIPEC for gastric cancer","volume":"32","author":"Badgwell","year":"2018","journal-title":"Surg Endosc"},{"issue":"1","key":"10.1016\/j.ejso.2025.109731_bib40","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s12885-020-6701-2","volume":"20","author":"Beeharry","year":"2020","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.ejso.2025.109731_bib41","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.3390\/cancers15041125","article-title":"10 Years of pressurized intraperitoneal aerosol chemotherapy (PIPAC): a systematic review and meta-analysis","volume":"15","author":"Di Giorgio","year":"2023","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.ejso.2025.109731_bib42","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1245\/s10434-013-3213-1","article-title":"Intraperitoneal chemotherapy of peritoneal carcinomatosis using pressurized aerosol as an alternative to liquid solution: first evidence for efficacy","volume":"21","author":"Solass","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2025.109731_bib43","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1515\/pp-2016-0017","article-title":"Bidirectional chemotherapy in gastric cancer with peritoneal metastasis combining intravenous XELOX with intraperitoneal chemotherapy with low-dose cisplatin and Doxorubicin administered as a pressurized aerosol: an open-label, Phase-2 study (PIPAC-GA2)","volume":"1","author":"Khomyakov","year":"2016","journal-title":"Pleura Peritoneum"},{"key":"10.1016\/j.ejso.2025.109731_bib44","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.suronc.2020.05.006","article-title":"Systemic chemotherapy and pressurized intraperitoneal aerosol chemotherapy (PIPAC): a bidirectional approach for gastric cancer peritoneal metastasis","volume":"34","author":"Di Giorgio","year":"2020","journal-title":"Surg Oncol"},{"key":"10.1016\/j.ejso.2025.109731_bib45","doi-asserted-by":"crossref","DOI":"10.1177\/1758835919846402","article-title":"Pressurized intraperitoneal aerosol chemotherapy with low-dose cisplatin and doxorubicin (PIPAC C\/D) in patients with gastric cancer and peritoneal metastasis: a phase II study","volume":"11","author":"Struller","year":"2019","journal-title":"Ther Adv Med Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2025.109731_bib46","doi-asserted-by":"crossref","DOI":"10.1515\/pp-2018-0116","article-title":"PIPAC EstoK 01: pressurized IntraPeritoneal Aerosol Chemotherapy with cisplatin and doxorubicin (PIPAC C\/D) in gastric peritoneal metastasis: a randomized and multicenter phase II study","volume":"3","author":"Eveno","year":"2018","journal-title":"Pleura Peritoneum"},{"issue":"3","key":"10.1016\/j.ejso.2025.109731_bib47","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1515\/pp-2022-0111","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in multimodal therapy for patients with oligometastatic peritoneal gastric cancer: a randomized multicenter phase III trial PIPAC VEROne","volume":"7","author":"Casella","year":"2022","journal-title":"Pleura Peritoneum"},{"issue":"6","key":"10.1016\/j.ejso.2025.109731_bib48","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1245\/s10434-011-1631-5","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial","volume":"18","author":"Yang","year":"2011","journal-title":"Ann Surg Oncol"},{"issue":"23","key":"10.1016\/j.ejso.2025.109731_bib49","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1200\/JCO.18.01688","article-title":"Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases (CYTO-CHIP study): a propensity score analysis","volume":"37","author":"Bonnot","year":"2019","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2025.109731_bib50","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1200\/JCO.22.02867","article-title":"Effect of hyperthermic intraperitoneal chemotherapy on cytoreductive surgery in gastric cancer with synchronous peritoneal metastases: the phase III GASTRIPEC-I trial","volume":"42","author":"Rau","year":"2024","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2025.109731_bib51","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/jso.23633","article-title":"Impact of maximal cytoreductive surgery plus regional heated intraperitoneal chemotherapy (HIPEC) on outcome of patients with peritoneal carcinomatosis of gastric origin: results of the GYMSSA trial","volume":"110","author":"Rudloff","year":"2014","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ejso.2025.109731_bib52","article-title":"Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for gastric cancer with intraoperative detection of limited peritoneal metastasis: a Phase II study of CLASS-05 trial","volume":"12","author":"Lin","year":"2024","journal-title":"Gastroenterol Rep"},{"issue":"1","key":"10.1016\/j.ejso.2025.109731_bib53","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1245\/s10434-023-14415-1","article-title":"Gastrectomy + cytoreductive surgery + HIPEC for gastric cancer with peritoneal dissemination (PERISCOPE II)","volume":"31","author":"Sarvestani","year":"2024","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2025.109731_bib54","first-page":"12","article-title":"Quality of life during palliative systemic therapy for esophagogastric cancer: systematic review and meta-analysis","volume":"112","author":"van Kleef","year":"2020","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.ejso.2025.109731_bib55","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1515\/pp-2021-0154","article-title":"A systematic review on quality of life (QoL) of patients with peritoneal metastasis (PM) who underwent pressurized intraperitoneal aerosol chemotherapy (PIPAC)","volume":"7","author":"Li","year":"2022","journal-title":"Pleura Peritoneum"},{"key":"10.1016\/j.ejso.2025.109731_bib56","doi-asserted-by":"crossref","DOI":"10.1177\/17588359231225038","article-title":"Analysis of circulating tumor DNA identifies distinct therapeutic response to intraperitoneal and intravenous paclitaxel plus S-1 in gastric cancer patients with peritoneal metastasis","volume":"16","author":"Yuan","year":"2024","journal-title":"Ther Adv Med Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2025.109731_bib57","doi-asserted-by":"crossref","first-page":"5997","DOI":"10.1245\/s10434-024-15592-3","article-title":"Circulating exosomal MicroRNA signature predicts peritoneal metastasis in patients with advanced gastric cancer","volume":"31","author":"Wada","year":"2024","journal-title":"Ann Surg Oncol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798325001593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798325001593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T14:49:47Z","timestamp":1753973387000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798325001593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":57,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0748798325001593"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2025.109731","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of peritoneal gastric metastasis: An update","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2025.109731","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109731"}}